YouGov’s (YOU) Buy Rating Reiterated at Berenberg Bank

YouGov (LON:YOU)‘s stock had its “buy” rating restated by equities researchers at Berenberg Bank in a research report issued on Tuesday, Digital Look reports. They currently have a GBX 395 price target on the stock. Berenberg Bank’s price target would indicate a potential upside of 34.45% from the stock’s current price.

YOU has been the topic of a number of other reports. JPMorgan Chase & Co. raised their target price on YouGov from GBX 360 to GBX 375 and gave the company an “overweight” rating in a research report on Friday, July 17th. Canaccord Genuity Group reaffirmed a “buy” rating and issued a GBX 450 price target on shares of YouGov in a report on Friday, August 7th. Five investment analysts have rated the stock with a Buy rating. According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 416.

YouGov Stock Down 4.1%

YOU opened at GBX 293.80 on Tuesday. YouGov has a fifty-two week low of GBX 135.40 and a fifty-two week high of GBX 319.40. The company has a debt-to-equity ratio of 34.19, a quick ratio of 0.99 and a current ratio of 0.73. The company has a fifty day moving average of GBX 267.01 and a two-hundred day moving average of GBX 230.55. The stock has a market capitalization of £344.22 million, a price-to-earnings ratio of 28.25, a PEG ratio of 0.71 and a beta of 1.41.

YouGov (LON:YOU) last issued its quarterly earnings data on Tuesday, October 13th. The company reported GBX 30.20 earnings per share for the quarter. YouGov had a net margin of 1.44% and a return on equity of 3.05%. On average, research analysts expect that YouGov will post 41.89 earnings per share for the current year.

YouGov News Summary

Here are the key news stories impacting YouGov this week:

• Positive Sentiment: YouGov is reportedly taking steps to exploit what management views as a market undervaluation, a potentially supportive signal for shareholders if it leads to capital returns, stronger investor communication or improved operating performance. YouGov moves to exploit perceived market undervaluation
• Positive Sentiment: Berenberg reaffirmed its “buy” rating and set a GBX 395 price target, implying substantial potential upside from the recent trading level. The unchanged bullish stance provides a positive valuation signal. Berenberg Bank Reaffirms Buy Rating for YouGov
• Neutral Sentiment: YouGov reported quarterly EPS of GBX 30.20, but its 1.44% net margin and 3.05% return on equity indicate that profitability remains modest. The results provide limited evidence of a major earnings catalyst without additional detail on revenue growth or guidance. YouGov Posts Earnings Results
• Neutral Sentiment: Recent YouGov polling showed Reform UK falling behind the Conservatives, while Nigel Farage trailed Kemi Badenoch. These reports reinforce YouGov’s visibility and relevance in political polling, but the individual poll outcomes are unlikely to materially affect near-term financial results. Farage falls behind Badenoch in latest YouGov poll
• Neutral Sentiment: Additional YouGov polling on public executions and royal popularity may support brand recognition and media reach, but these stories have little direct impact on revenue or valuation. Majority of Americans oppose public executions poll

About YouGov

YouGov is a global research data and analytics group. Our mission is to offer unparalleled insight into what the world really thinks and does. With operations in the Americas, Mainland Europe, UK and Asia Pacific, we have one of the world’s largest research networks.

Above all, YouGov is powered by reality. That stems from a unique panel of millions of registered members across 64 markets, encapsulating some 18 million shopping trips and millions of interconnected data points. Our unique approach to recruiting and engaging with our panel, combined with our state-of-the-art technology platforms, enables us to deliver real-world, real-time insights that lead to better decision-making and a competitive advantage for our clients.